Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The exact underlying mechanisms of ulcerative colitis (UC), an idiopathic, chronic inflammatory disease marked by diffused inflammation of the colon and rectum mucosa, are still unknown. Due to genetic, immune, and environmental factors, UC is highly dependent on cellular immune reactions and exaggerated inflammatory responses. The release of several cytokines, kinins, leukotrienes, platelet-activating factor (PAF), and reactive oxygen species is connected to immunological activity (ROS). Additionally, many of the cytokines will start an acute phase response, making the inflammation worse.
Epistemonikos ID: cfc1f0024d3af7247fa91248f68935f1b29b6912
First added on: May 13, 2024